- Home
- SOHO vs CLDI Comparison
SOHO vs CLDI Comparison
Compare SOHO & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- CLDI
- Stock Information
- Founded
- SOHO 2004
- CLDI 2014
- Country
- SOHO United States
- CLDI United States
- Employees
- SOHO N/A
- CLDI N/A
- Industry
- SOHO Real Estate Investment Trusts
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOHO Real Estate
- CLDI Health Care
- Exchange
- SOHO Nasdaq
- CLDI Nasdaq
- Market Cap
- SOHO 16.3M
- CLDI 15.7M
- IPO Year
- SOHO 2004
- CLDI N/A
- Fundamental
- Price
- SOHO $0.79
- CLDI $0.40
- Analyst Decision
- SOHO Hold
- CLDI Strong Buy
- Analyst Count
- SOHO 1
- CLDI 2
- Target Price
- SOHO $1.50
- CLDI $15.00
- AVG Volume (30 Days)
- SOHO 19.2K
- CLDI 202.0K
- Earning Date
- SOHO 05-13-2025
- CLDI 05-20-2025
- Dividend Yield
- SOHO N/A
- CLDI N/A
- EPS Growth
- SOHO N/A
- CLDI N/A
- EPS
- SOHO N/A
- CLDI N/A
- Revenue
- SOHO $182,158,199.00
- CLDI N/A
- Revenue This Year
- SOHO $13.93
- CLDI N/A
- Revenue Next Year
- SOHO N/A
- CLDI N/A
- P/E Ratio
- SOHO N/A
- CLDI N/A
- Revenue Growth
- SOHO 3.11
- CLDI N/A
- 52 Week Low
- SOHO $0.59
- CLDI $0.35
- 52 Week High
- SOHO $1.54
- CLDI $4.90
- Technical
- Relative Strength Index (RSI)
- SOHO 60.78
- CLDI 34.35
- Support Level
- SOHO $0.70
- CLDI $0.41
- Resistance Level
- SOHO $0.83
- CLDI $0.46
- Average True Range (ATR)
- SOHO 0.05
- CLDI 0.04
- MACD
- SOHO 0.01
- CLDI 0.01
- Stochastic Oscillator
- SOHO 71.38
- CLDI 0.00
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.